Create account

Coverage dated September 30, 2026

This Pill Will Change Cancer Treatment Forever

Headline from Gizmodo

Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.

Gizmodo's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. The Good Men Project

    FDA Approves Breakthrough Pancreatic Cancer Drug – An Oncologist Explains How Daraxonrasib Nearly Doubles Survival (opens The Good Men Project)

    Published

    The Good Men Project's feed description

    The FDA’s approval of daraxonrasib marks a significant development in pancreatic cancer treatment, with clinical trial results suggesting the drug can substantially extend survival for some patients.

  2. Gizmodo

    This Pill Will Change Cancer Treatment Forever (opens Gizmodo)

    Published

    Gizmodo's feed description

    Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.

This Pill Will Change Cancer Treatment Forever | Since Then